Neil Baladkar
Vice President of Investor Relations
Replay available
Kestra Medical Technologies, Ltd. (KMTS) Q2 2026 Earnings Call
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) Q2 2026 earnings conference call, held 2025-12-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Webster
President and Chief Executive Officer
Vasim Mahbub
Chief Financial Officer
Matthew O'Brien
Analyst, Piper Sandler
Larry Beagleson
Analyst, Wells Fargo Securities
Michael Polark
Analyst, Wolf Research
David Roman
Analyst, Goldman Sachs
Marie Thibault
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Kestra Medical Technologies, Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.278 Good afternoon and welcome to Castro Medical Technology's second quarter fiscal 2026 00:00:05.278 -- 00:00:10.244 earnings call. This conference call is being recorded for replay purposes. 00:00:10.244 -- 00:00:14.409 We will be facilitating a question and answer session following some fair remarks from 00:00:14.409 -- 00:00:18.915 management at this time. All participants are in a listen-only mode. 00:00:18.915 -- 00:00:23.481 I would now like to turn the call over to Neil Baladkar, Vice President of Investor Relations, 00:00:23.481 -- 00:00:26.104 for introductory comments. 00:00:26.104 -- 00:00:31.166 Thank you, Victor. Thank you for joining Testra's second quarter fiscal 2026 earnings 00:00:31.166 -- 00:00:36.312 call. With me today are Brian Webster, President and Chief Executive Officer, and 00:00:36.312 -- 00:00:41.419 Vasim Mahbub, Chief Financial Officer. This call includes forward-looking statements 00:00:41.419 -- 00:00:46.325 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:46.325 -- 00:00:51.051 Statements made on this call that do not relate to matters of historical fact should 00:00:51.051 -- 00:00:55.472 be considered forward-looking statements. These statements are based on Kestra's current 00:00:55.472 -- 00:01:00.636 expectations, forecasts, and assumptions, which are subject to inherent uncertainties, 00:01:00.636 -- 00:01:03.959 risks, and assumptions that are difficult to predict. 00:01:03.959 -- 00:01:08.683 Actual outcomes and results could differ materially from any results, performance, or 00:01:08.683 -- 00:01:13.988 achievements expressed or implied by the forward-looking statements due to various factors. 00:01:13.988 -- 00:01:18.932 Please review Kestra's most recent fi...